Search results
Milwaukee police pursuit, driver arrested; drugs, 'ghost gun' found
WITI via Yahoo News· 3 days agoSeveral bags were also recovered. One bag had multicolored and multi-shaped pills suspected to be...
Infinitus Systems Inc. launches AI instant benefit verification solution for Medicare Part B |...
Healthcare Dive· 16 hours agoInfinitus Systems, Inc., the healthcare AI company that automates the collection of data traditionally gathered via manual phone calls, today announced an instantaneous, proprietary digital ...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in...
WTRF Wheeling· 11 hours agoFood and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to larsucosterol for the treatment of patients with severe alcohol-associated hepatitis ...
Earnings call: Belite Bio highlights progress in key drug trials, Q1 financials By Investing.com
Investing.com· 6 days agoDespite reporting increased research and development expenses and a net loss for the quarter, Belite...
Washington County Grand Jury
The Marietta Times· 6 days agoThe Washington County Grand Jury indicted 24 people this week on a variety of charges. The following indictments were issued: * Marcus Evan MacAuley, 18, Marietta, third-degree strangulation ...
Salzburg Intensive Care database (SICdb): a detailed exploration and comparative analysis with...
Nature· 2 days agoThe data in the SICdb have been anonymized in accordance with article 4(5) of the European General Data Protection Regulation (GDPR) 28. The database includes data exclusively from ICU patients ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoPreliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell
Carisma Therapeutics begins trial for novel cancer therapy By Investing.com
Investing.com· 5 days agoCarisma Therapeutics Inc. (NASDAQ: CARM), a biopharmaceutical company, announced today the...
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
Morningstar· 5 days agoEnrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025Company committed to addressing the most aggressive type of brain cancer ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoAvenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic ...